The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Supaverm Oral Suspension

Elanco GmbHVPA22020/031/001

Main Information

Trade NameSupaverm Oral Suspension
Active SubstancesClosantel sodium dihydrate
Dosage FormOral suspension
Licence HolderElanco GmbH
Licence NumberVPA22020/031/001

Group Information

ATC CodeQP52AC09 mebendazole
QP52AG09 closantel
Therapeutic ClassEndoparasiticide


Licence Issued27/04/2012
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back